257 related articles for article (PubMed ID: 12633696)
21. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
22. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
Ohata K; Chen-Yoshikawa TF; Takahashi K; Aoyama A; Motoyama H; Hijiya K; Hamaji M; Menju T; Sato T; Sonobe M; Takakura S; Date H
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):710-715. PubMed ID: 29049752
[TBL] [Abstract][Full Text] [Related]
24. The killer immunoglobulin-like receptor (KIR) group A haplotype is associated with bronchiolitis obliterans syndrome after lung transplantation.
Kwakkel-van Erp JM; van de Graaf EA; Paantjens AW; van Ginkel WG; Schellekens J; van Kessel DA; van den Bosch JM; Otten HG
J Heart Lung Transplant; 2008 Sep; 27(9):995-1001. PubMed ID: 18765192
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
[TBL] [Abstract][Full Text] [Related]
26. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin.
Gutiérrez CA; Chaparro C; Krajden M; Winton T; Kesten S
Chest; 1998 Apr; 113(4):924-32. PubMed ID: 9554627
[TBL] [Abstract][Full Text] [Related]
27. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation.
Safavi S; Robinson DR; Soresi S; Carby M; Smith JD
J Heart Lung Transplant; 2014 Dec; 33(12):1273-81. PubMed ID: 25130554
[TBL] [Abstract][Full Text] [Related]
28. Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients.
Kruger RM; Paranjothi S; Storch GA; Lynch JP; Trulock EP
J Heart Lung Transplant; 2003 Jul; 22(7):754-63. PubMed ID: 12873543
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
30. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.
Morrell MR; Pilewski JM; Gries CJ; Pipeling MR; Crespo MM; Ensor CR; Yousem SA; D'Cunha J; Shigemura N; Bermudez CA; McDyer JF; Zeevi A
J Heart Lung Transplant; 2014 Dec; 33(12):1288-94. PubMed ID: 25443870
[TBL] [Abstract][Full Text] [Related]
31. Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients.
Stratta RJ; Alloway RR; Lo A; Hodge EE;
Transplant Proc; 2004 May; 36(4):1082-3. PubMed ID: 15194376
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of current strategies for surveillance and management of donor-specific antibodies: Single-center study.
Sullivan D; Ahn C; Gao A; Lacelle C; Torres F; Bollineni S; Banga A; Mullins J; Mohanka M; Ring S; Wait M; Peltz M; Duddupudi P; Surapaneni D; Kaza V
Clin Transplant; 2018 Jul; 32(7):e13285. PubMed ID: 29774598
[TBL] [Abstract][Full Text] [Related]
33. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
Valentine VG; Weill D; Gupta MR; Raper B; Laplace SG; Lombard GA; Bonvillain RW; Taylor DE; Dhillon GS
J Heart Lung Transplant; 2008 Aug; 27(8):875-81. PubMed ID: 18656801
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
[TBL] [Abstract][Full Text] [Related]
35. Role of CMV pneumonia in the development of obliterative bronchiolitis in heart-lung and double-lung transplant recipients.
Cerrina J; Le Roy Ladurie F; Herve PH; Parquin F; Harari S; Chapelier A; Simoneau G; Vouhe P; Dartevelle PH
Transpl Int; 1992; 5 Suppl 1():S242-5. PubMed ID: 14621790
[TBL] [Abstract][Full Text] [Related]
36. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.
Sharples LD; Tamm M; McNeil K; Higenbottam TW; Stewart S; Wallwork J
Transplantation; 1996 Feb; 61(4):560-6. PubMed ID: 8610381
[TBL] [Abstract][Full Text] [Related]
37. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
38. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation.
Chmiel C; Speich R; Hofer M; Michel D; Mertens T; Weder W; Boehler A
Clin Infect Dis; 2008 Mar; 46(6):831-9. PubMed ID: 18269330
[TBL] [Abstract][Full Text] [Related]
39. Human leukocyte antigen-DR13 and DR15 are associated with short-term lung transplant outcomes.
Gracon AS; Liang TW; Rothhaar K; Wu J; Wilkes DS
J Surg Res; 2016 Jun; 203(1):82-90. PubMed ID: 27338538
[TBL] [Abstract][Full Text] [Related]
40. Combined cytomegalovirus prophylaxis in lung transplantation: effects on acute rejection, lymphocytic bronchitis/bronchiolitis, and herpesvirus infections.
Solidoro P; Libertucci D; Delsedime L; Ruffini E; Bosco M; Costa C; Rinaldi M; Baldi S
Transplant Proc; 2008; 40(6):2013-4. PubMed ID: 18675117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
